APPA PDUFA Date of 3/18/10. Very clear that the FDA has all of the information that they need in approving this drug. The only difference is the formulation of the granisetron which allows for 5 days of the drug. No additional information that the FDA needs from the company. This is a solid forward-looking event play! $heff